These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22739569)

  • 21. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Lisman T; Porte RJ
    N Engl J Med; 2012 Nov; 367(21):2055-6. PubMed ID: 23171114
    [No Abstract]   [Full Text] [Related]  

  • 22. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Violi F; Pignatelli P
    N Engl J Med; 2012 Nov; 367(21):2056. PubMed ID: 23171115
    [No Abstract]   [Full Text] [Related]  

  • 23. Eltrombopag in thrombocytopenia.
    Zimmer J; Hentges F; Andrès E
    N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18326076
    [No Abstract]   [Full Text] [Related]  

  • 24. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
    Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
    [No Abstract]   [Full Text] [Related]  

  • 25. Absence of bi-directional cross-resistance of thrombopoietin receptor agonists in chronic refractory immune thrombocytopenia: possible role of MPL polymorphisms.
    Polverelli N; Palandri F; Iacobucci I; Catani L; Martinelli G; Vianelli N
    Br J Haematol; 2013 Apr; 161(1):142-4. PubMed ID: 23278214
    [No Abstract]   [Full Text] [Related]  

  • 26. Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures.
    Castelli R; Gidaro A; Lambertenghi Deliliers G
    Blood Coagul Fibrinolysis; 2021 Mar; 32(2):163-166. PubMed ID: 33555693
    [No Abstract]   [Full Text] [Related]  

  • 27. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
    Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eltrombopag for the treatment of immune thrombocytopenia.
    Cheng G
    Expert Rev Hematol; 2011 Jun; 4(3):261-9. PubMed ID: 21671710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eltrombopag in patients with chronic liver disease.
    Giannini EG; Afdhal NH
    Expert Opin Pharmacother; 2013 Apr; 14(5):669-78. PubMed ID: 23452139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus.
    Magnano L; Enríquez H; Esteve J; Cervera R; Espinosa G
    J Rheumatol; 2014 Sep; 41(9):1895-6. PubMed ID: 25179983
    [No Abstract]   [Full Text] [Related]  

  • 31. Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia.
    Hayes S; Mudd PN; Ouellet D; Johnson BM; Williams D; Gibiansky E
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1507-20. PubMed ID: 23564375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of thrombopoietin receptor agonists].
    Miyakawa Y
    Rinsho Ketsueki; 2009 Oct; 50(10):1434-43. PubMed ID: 19915352
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia.
    Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H
    Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773
    [No Abstract]   [Full Text] [Related]  

  • 34. Eltrombopag to allow chemotherapy in a patient with MYH9-related inherited thrombocytopenia and pancreatic cancer.
    Paciullo F; Bury L; Gresele P
    Int J Hematol; 2020 Nov; 112(5):725-727. PubMed ID: 32557126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is publication? The case of eltrombopag.
    Benham L; Guo L; Turner R
    Lancet; 2011 Jan; 377(9763):360-1. PubMed ID: 21277427
    [No Abstract]   [Full Text] [Related]  

  • 36. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia.
    Afdhal NH; Giannini EG; Tayyab G; Mohsin A; Lee JW; Andriulli A; Jeffers L; McHutchison J; Chen PJ; Han KH; Campbell F; Hyde D; Brainsky A; Theodore D;
    N Engl J Med; 2012 Aug; 367(8):716-24. PubMed ID: 22913681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia.
    Favier R; Feriel J; Favier M; Denoyelle F; Martignetti JA
    Pediatrics; 2013 Sep; 132(3):e793-5. PubMed ID: 23940247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.
    Cheng G; Saleh MN; Marcher C; Vasey S; Mayer B; Aivado M; Arning M; Stone NL; Bussel JB
    Lancet; 2011 Jan; 377(9763):393-402. PubMed ID: 20739054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eltrombopag to Treat Thrombocytopenia During Last Month of Pregnancy in a Woman With MYH9-Related Disease: A Case Report.
    Favier R; De Carne C; Elefant E; Lapusneanu R; Gkalea V; Rigouzzo A
    A A Pract; 2018 Jan; 10(1):10-12. PubMed ID: 28795988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of eltrombopag for surgical preparation in a patient with ANKRD26-related thrombocytopenia.
    Fiore M; Saut N; Alessi MC; Viallard JF
    Platelets; 2016 Dec; 27(8):828-829. PubMed ID: 27276516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.